Galaxy Surfactants Limited Logo

Galaxy Surfactants Limited

GALAXYSURF.NS

(3.5)
Stock Price

2.731,80 INR

10.53% ROA

15.07% ROE

33.09x PER

Market Cap.

101.271.317.980,00 INR

6.43% DER

0.77% Yield

8% NPM

Galaxy Surfactants Limited Stock Analysis

Galaxy Surfactants Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Galaxy Surfactants Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (50.99%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (0x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

6 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

7 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (38.776) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 ROA

The stock's ROA (0%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

10 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

11 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

Galaxy Surfactants Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Galaxy Surfactants Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Galaxy Surfactants Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Galaxy Surfactants Limited Revenue
Year Revenue Growth
2012 15.807.360.000
2013 16.972.940.000 6.87%
2014 18.739.360.000 9.43%
2015 18.019.110.000 -4%
2016 21.613.430.000 16.63%
2017 24.127.500.000 10.42%
2018 27.318.200.000 11.68%
2019 25.632.800.000 -6.58%
2020 27.453.500.000 6.63%
2021 36.527.200.000 24.84%
2022 44.452.400.000 17.83%
2023 39.324.800.000 -13.04%
2023 37.943.800.000 -3.64%
2024 38.962.400.000 2.61%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Galaxy Surfactants Limited Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 102.750.000 100%
2015 121.030.000 15.1%
2016 265.800.000 54.47%
2017 260.399.999 -2.07%
2018 261.100.000 0.27%
2019 269.000.000 2.94%
2020 269.200.000 0.07%
2021 293.400.000 8.25%
2022 275.000.000 -6.69%
2023 0 0%
2023 308.400.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Galaxy Surfactants Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 181.120.000
2013 209.370.000 13.49%
2014 220.050.000 4.85%
2015 245.670.000 10.43%
2016 252.200.000 2.59%
2017 235.500.000 -7.09%
2018 233.100.000 -1.03%
2019 342.500.000 31.94%
2020 377.500.000 9.27%
2021 380.800.000 0.87%
2022 445.800.000 14.58%
2023 0 0%
2023 504.800.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Galaxy Surfactants Limited EBITDA
Year EBITDA Growth
2012 1.194.630.000
2013 2.114.430.000 43.5%
2014 1.856.040.000 -13.92%
2015 2.334.880.000 20.51%
2016 2.717.610.000 14.08%
2017 2.977.100.000 8.72%
2018 3.587.100.000 17.01%
2019 3.754.400.000 4.46%
2020 4.665.600.000 19.53%
2021 4.127.700.000 -13.03%
2022 5.781.300.000 28.6%
2023 5.102.800.000 -13.3%
2023 4.622.200.000 -10.4%
2024 4.963.200.000 6.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Galaxy Surfactants Limited Gross Profit
Year Gross Profit Growth
2012 4.025.730.000
2013 5.179.280.000 22.27%
2014 5.419.180.000 4.43%
2015 5.937.460.000 8.73%
2016 6.267.130.000 5.26%
2017 6.501.700.000 3.61%
2018 7.716.600.000 15.74%
2019 8.340.100.000 7.48%
2020 9.547.900.000 12.65%
2021 10.448.500.000 8.62%
2022 13.451.600.000 22.33%
2023 12.372.400.000 -8.72%
2023 8.411.200.000 -47.09%
2024 8.943.200.000 5.95%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Galaxy Surfactants Limited Net Profit
Year Net Profit Growth
2012 2.780.000
2013 759.970.000 99.63%
2014 674.560.000 -12.66%
2015 1.027.180.000 34.33%
2016 1.463.060.000 29.79%
2017 1.580.300.000 7.42%
2018 1.909.800.000 17.25%
2019 2.304.100.000 17.11%
2020 3.021.400.000 23.74%
2021 2.627.800.000 -14.98%
2022 3.809.800.000 31.03%
2023 3.096.800.000 -23.02%
2023 3.014.700.000 -2.72%
2024 3.188.800.000 5.46%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Galaxy Surfactants Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 21 100%
2014 19 -10.53%
2015 29 32.14%
2016 42 31.71%
2017 45 6.82%
2018 54 16.98%
2019 65 17.19%
2020 85 24.71%
2021 74 -14.86%
2022 107 30.84%
2023 87 -22.99%
2023 85 -2.35%
2024 90 4.49%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Galaxy Surfactants Limited Free Cashflow
Year Free Cashflow Growth
2012 115.760.000
2013 1.234.660.000 90.62%
2014 237.220.000 -420.47%
2015 1.101.480.000 78.46%
2016 667.790.000 -64.94%
2017 872.500.000 23.46%
2018 1.139.900.000 23.46%
2019 1.745.500.000 34.69%
2020 2.575.000.000 32.21%
2021 -1.502.400.000 271.39%
2022 4.268.700.000 135.2%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Galaxy Surfactants Limited Operating Cashflow
Year Operating Cashflow Growth
2012 761.460.000
2013 1.707.860.000 55.41%
2014 593.620.000 -187.7%
2015 1.841.780.000 67.77%
2016 1.128.590.000 -63.19%
2017 1.442.000.000 21.73%
2018 2.829.300.000 49.03%
2019 3.161.500.000 10.51%
2020 3.650.500.000 13.4%
2021 49.300.000 -7304.67%
2022 5.729.500.000 99.14%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Galaxy Surfactants Limited Capital Expenditure
Year Capital Expenditure Growth
2012 645.700.000
2013 473.200.000 -36.45%
2014 356.400.000 -32.77%
2015 740.300.000 51.86%
2016 460.800.000 -60.66%
2017 569.500.000 19.09%
2018 1.689.400.000 66.29%
2019 1.416.000.000 -19.31%
2020 1.075.500.000 -31.66%
2021 1.551.700.000 30.69%
2022 1.460.800.000 -6.22%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Galaxy Surfactants Limited Equity
Year Equity Growth
2012 2.413.150.000
2013 3.222.500.000 25.12%
2014 3.778.890.000 14.72%
2015 4.503.400.000 16.09%
2016 5.726.120.000 21.35%
2017 7.187.700.000 20.33%
2018 8.767.300.000 18.02%
2019 10.677.500.000 17.89%
2020 13.014.100.000 17.95%
2021 15.743.500.000 17.34%
2022 18.825.500.000 16.37%
2023 21.792.500.000 13.61%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Galaxy Surfactants Limited Assets
Year Assets Growth
2012 9.556.850.000
2013 10.240.810.000 6.68%
2014 10.602.190.000 3.41%
2015 11.097.800.000 4.47%
2016 12.853.830.000 13.66%
2017 14.553.900.000 11.68%
2018 15.679.800.000 7.18%
2019 18.119.500.000 13.46%
2020 20.494.700.000 11.59%
2021 26.005.500.000 21.19%
2022 27.344.500.000 4.9%
2023 29.146.800.000 6.18%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Galaxy Surfactants Limited Liabilities
Year Liabilities Growth
2012 7.143.700.000
2013 7.018.310.000 -1.79%
2014 6.823.300.000 -2.86%
2015 6.594.400.000 -3.47%
2016 7.127.710.000 7.48%
2017 7.366.200.000 3.24%
2018 6.912.500.000 -6.56%
2019 7.442.000.000 7.12%
2020 7.480.600.000 0.52%
2021 10.262.000.000 27.1%
2022 8.519.000.000 -20.46%
2023 7.354.300.000 -15.84%

Galaxy Surfactants Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1079.31
Net Income per Share
86.31
Price to Earning Ratio
33.09x
Price To Sales Ratio
2.65x
POCF Ratio
68.81
PFCF Ratio
68.81
Price to Book Ratio
4.65
EV to Sales
2.63
EV Over EBITDA
21.34
EV to Operating CashFlow
68.46
EV to FreeCashFlow
68.46
Earnings Yield
0.03
FreeCashFlow Yield
0.01
Market Cap
101,27 Bil.
Enterprise Value
100,75 Bil.
Graham Number
1092.54
Graham NetNet
119.92

Income Statement Metrics

Net Income per Share
86.31
Income Quality
0.49
ROE
0.15
Return On Assets
0.1
Return On Capital Employed
0.16
Net Income per EBT
0.81
EBT Per Ebit
1.02
Ebit per Revenue
0.1
Effective Tax Rate
0.19

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.27
Operating Profit Margin
0.1
Pretax Profit Margin
0.1
Net Profit Margin
0.08

Dividends

Dividend Yield
0.01
Dividend Yield %
0.77
Payout Ratio
0
Dividend Per Share
22

Operating Metrics

Operating Cashflow per Share
41.51
Free CashFlow per Share
41.51
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.13
Return on Tangible Assets
0.11
Days Sales Outstanding
56.63
Days Payables Outstanding
58.36
Days of Inventory on Hand
72.75
Receivables Turnover
6.45
Payables Turnover
6.25
Inventory Turnover
5.02
Capex per Share
0

Balance Sheet

Cash per Share
123,35
Book Value per Share
614,66
Tangible Book Value per Share
612.56
Shareholders Equity per Share
614.66
Interest Debt per Share
45.35
Debt to Equity
0.06
Debt to Assets
0.05
Net Debt to EBITDA
-0.11
Current Ratio
2.82
Tangible Asset Value
21,72 Bil.
Net Current Asset Value
9,67 Bil.
Invested Capital
22303700000
Working Capital
10,99 Bil.
Intangibles to Total Assets
0
Average Receivables
2,97 Bil.
Average Payables
2,23 Bil.
Average Inventory
2780250000
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Galaxy Surfactants Limited Dividends
Year Dividends Growth
2018 7
2019 8 12.5%
2020 6 -33.33%
2021 18 66.67%
2022 18 0%
2023 22 18.18%
2024 22 0%

Galaxy Surfactants Limited Profile

About Galaxy Surfactants Limited

Galaxy Surfactants Limited manufactures and markets specialty chemicals for personal and home care industries in India and internationally. The company offers fatty alcohol surfactants, fatty alcohol ethoxylates, alkyl benzene sulphonic acids, foam and viscosity boosters, mild surfactants, pearlizers, surfactant blends, syndet and TBB, sunscreens, preservatives, and blends, as well as emollients, conditioning agents, hair color protector, scalp care, and anti-microbials. It serves the skin, hair, sun, oral, baby, and home care markets. The company was founded in 1980 and is based in Navi Mumbai, India.

CEO
Mr. Natarajan Krishnan Kuluman
Employee
1.762
Address
C-49/2, TTC Industrial Area
Navi Mumbai, 400703

Galaxy Surfactants Limited Executives & BODs

Galaxy Surfactants Limited Executives & BODs
# Name Age
1 Mr. Gopalkrishnan Ramakrishnan F.CA, FICWA ACS, M.Com.
Strategic Advisor & Non-Executive Non-Independent Director
70
2 Mr. Yogesh Kalra
Vice President of Business Creation
70
3 Mr. Niranjan Arun Ketkar
Company Secretary & Compliance Officer
70
4 Mr. Anand Gurav
Head of Business Commercial and Operations
70
5 Mr. Kamaljit Sahota
Head of IT and Communication Management
70
6 Mr. Abhijit Damle
Chief Financial Officer
70
7 Mr. Vaijanath S. Kulkarni
Chief Operating Officer & Executive Director
70
8 Dr. Sagar Anil Trailokya
Vice President of Quality
70
9 Mr. Garikiparthy Sesha Samba Murty
Vice President of Conversion
70
10 Mr. Natarajan Krishnan Kulumani A.I.C.W.A, B.Com..
MD & Executive Director
70

Galaxy Surfactants Limited Competitors

Alkyl Amines Chemicals Limited Logo
Alkyl Amines Chemicals Limited

ALKYLAMINE.NS

(3.5)
GMM Pfaudler Limited Logo
GMM Pfaudler Limited

GMMPFAUDLR.NS

(3.5)
Vinati Organics Limited Logo
Vinati Organics Limited

VINATIORGA.NS

(3.0)